SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11693900
Source:
http://linkedlifedata.com/resource/pubmed/id/11693900
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0006142
,
umls-concept:C0013216
,
umls-concept:C0030705
,
umls-concept:C0205269
,
umls-concept:C0600558
,
umls-concept:C0681890
,
umls-concept:C1274040
,
umls-concept:C1521761
pubmed:issue
5
pubmed:dateCreated
2001-11-5
pubmed:abstractText
The purpose of this study was to determine the clinical, pathological, and treatment factors that are predictive of local-regional recurrence and overall survival for patients with breast cancer that is refractory to neoadjuvant chemotherapy.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/CA16672
,
http://linkedlifedata.com/resource/pubmed/grant/T32CA77050
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100931981
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
1528-9117
pubmed:author
pubmed-author:BuchholzT ATA
,
pubmed-author:BuzdarA UAU
,
pubmed-author:FryeD KDK
,
pubmed-author:HillB SBS
,
pubmed-author:HortobagyiG NGN
,
pubmed-author:KuererH MHM
,
pubmed-author:McNeeseM DMD
,
pubmed-author:PusztaiLL
,
pubmed-author:SingletaryS ESE
,
pubmed-author:TuckerS LSL
,
pubmed-author:UenoN TNT
,
pubmed-author:ValeroVV
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
413-20
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11693900-Adult
,
pubmed-meshheading:11693900-Analysis of Variance
,
pubmed-meshheading:11693900-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:11693900-Breast Neoplasms
,
pubmed-meshheading:11693900-Chemotherapy, Adjuvant
,
pubmed-meshheading:11693900-Female
,
pubmed-meshheading:11693900-Humans
,
pubmed-meshheading:11693900-Middle Aged
,
pubmed-meshheading:11693900-Neoadjuvant Therapy
,
pubmed-meshheading:11693900-Neoplasm Recurrence, Local
,
pubmed-meshheading:11693900-Proportional Hazards Models
,
pubmed-meshheading:11693900-Retrospective Studies
,
pubmed-meshheading:11693900-Survival Rate
,
pubmed-meshheading:11693900-Treatment Outcome
pubmed:articleTitle
Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy.
pubmed:affiliation
Department of Radiation Oncology,The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
pubmed:publicationType
Journal Article
,
Research Support, U.S. Gov't, P.H.S.
,
Research Support, U.S. Gov't, Non-P.H.S.